ADC Therapeutics SA (ADCT) is a publicly traded Healthcare sector company. As of September 3, 2026, ADCT trades at $1.35 with a market cap of $158.31M and a P/E ratio of -2.19. ADCT moved +1.89% today. Year to date, ADCT is -62.50%; over the trailing twelve months it is -59.88%. Its 52-week range spans $0.78 to $4.98. Analyst consensus is buy with an average price target of $4.00. Rallies surfaces ADCT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for ADCT shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $1.35 |
| Market Cap | $158.31M |
| P/E Ratio | -2.19 |
| EPS | $-0.60 |
| Dividend Yield | 0.00% |
| 52-Week High | $4.98 |
| 52-Week Low | $0.78 |
| Volume | 111.33K |
| Avg Volume | 0 |
| Revenue (TTM) | $79.58M |
| Net Income | $-96.91M |
| Gross Margin | 0.00% |
4 analysts cover ADCT: 0 strong buy, 2 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $4.00.